USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ASPIRA BIOSYSTEMS, INC.
Address:
ASPIRA BIOSYSTEMS, INC.
571 ECCLES AVE
SOUTH SAN FRANCISCO, CA 94080
Phone:
(650) 246-8501
URL:
N/A
EIN:
943352082
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $108,000.00 2
SBIR Phase II $1,109,750.00 1

Award List:

AN ARTIFICIAL SEQUENCE-BASED PROTEIN RECEPTOR ARRAY

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$108,000.00
Agency:
HHS
Principal Investigator:
Chinshiou Huang
Abstract:
DESCRIPTION (applicant's abstract): Our goal under this SBIR is to demonstrate the feasibility of using a novel Artificial Sequence-based Protein REceptor (ASPIRE) for the creation of a "protein chip." The development of new protein separation technology is essential to bridge… More

An Artificial Sequence-based Protein Receptor Array

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Our goal under this Phase II SBIR is to demonstrate that Protein Print TM Arrays can be effectively used for parallel expression profiling of biomarkers and novel therapeutic targets. As part of this work we will generate a commercially viable biomarker array… More

An Artificial Sequence-based Protein Receptor Array

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$1,109,750.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Our goal under this Phase II SBIR is to demonstrate that Protein Print TM Arrays can be effectively used for parallel expression profiling of biomarkers and novel therapeutic targets. As part of this work we will generate a commercially viable biomarker array… More